Delivery Order SPE2DB20D1100-SPE2DB25FB3K4
Award Date
3/25/25
Potential Completion Date
3/26/25
Potential Value
$3.8K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $19,840.64, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order (DO) under DLA's Indefinite Delivery Contract (IDC) valued at $999,999,999, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract is for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,718.59 firm-fixed-price delivery order is for the supply of ORILISSA 150 MG TABLET 7S, a pharmaceutical product. The contract has a period of performance through November 5, 2024 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery...
This federal contract award, valued at $8,686.03, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order to provide ORILISSA 150 MG TABLET 7S, a specialty medication. The contract has an ultimate completion date of October 23, 2024 and is a firm fixed-price agreement. This contract award is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop...
This federal contract award, identified as SPE2DB20D2104|SPE2DB25FMPFJ, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $6,474.25 firm fixed-price delivery order is for the supply of ORILISSA 150 MG TABLET 7S, a medication, with a performance period through April 2025. The contract is not set aside and is considered an open competition. Amerisourcebergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,756.28 firm fixed-price delivery order is for the supply of ORILISSA 150 MG TABLET 7S, a prescription medication. The contract has an ultimate completion date of April 3, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an award value of $3,863.66 and is a delivery order for ORILISSA 150 MG TABLET 7S. The contract has no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This federal contract award, valued at $2,251.53, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ORILISSA 150 MG TABLET 7S, a pharmaceutical product. The contract has an ultimate completion date of January 13, 2025 and is a Firm Fixed Price Delivery Order. The contract is not designated with a set-aside. AmerisourceBergen Drug Corp holds a significant...
This federal contract award, SPE2DB20D3101|SPE2DB25FQUY9, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. The $9,323.10 Firm Fixed Price delivery order is for the pharmaceutical product ORILISSA 150 MG TABLET 7S. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support...
This federal contract award, with ID SPE2DB22D3301|SPE2DB25FX9JX, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,896.93 firm fixed-price delivery order is for the supply of 4567117460 - ORILISSA 200 MG TABLET 14S, a pharmaceutical product. The contract has an ultimate completion date of February 3, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) that...
This federal contract award, with an ID of SPE2DB22D3102|SPE2DB24FL2ZS, was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $7,240.01 firm fixed price delivery order is for the supply of 4565810946 ORILISSA 150 MG TABLET 7S, a prescription medication. The contract has a period of performance through September 16, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) valued at up to $999,999,999 with the...